A call for change
Scottish swimmer Archie Goodburn is heading to Downing Street today for a high-stakes meeting with the Prime Minister. The 25-year-old athlete, who competed in the 50m breaststroke final at the 2026 Commonwealth Games, is using his platform to demand urgent investment in brain cancer research.
The reality of the diagnosis
Goodburn’s journey shifted in 2024 when he started experiencing seizures and numbness while training for the Olympic trials. He was diagnosed with three large oligodendrogliomas—a rare type of cancer affecting the brain and spinal cord. While he went through rigorous chemotherapy and radiotherapy, doctors ultimately determined the tumors were inoperable.
Why he's speaking out
Following an emotional appeal on BBC Breakfast where he said he was "on my knees begging" for help, Goodburn successfully secured a meeting with the PM. He is advocating for a dedicated national brain cancer lead to better coordinate resources.
"Please establish a national brain cancer lead and give us a chance to fight for our lives because the things that patients are going through out there are unbelievable and so unjust," Goodburn said. He’s specifically calling for the UK to bring in international clinical trials that are already making waves in the US, Australia, and China, arguing that current UK systems are too risk-averse.
The current landscape
According to the charity Brain Tumour Research, this condition is the leading cause of cancer death in the UK for people under 40. Currently, charities shoulder about 75% of the funding burden, while the government provides the remaining 25%.
While the recently passed Rare Cancers Bill aims to boost investment for diseases affecting fewer than 1 in 2,000 people, Goodburn feels it isn’t enough. Edinburgh South West MP Scott Arthur, who championed that bill, noted that while the act is "vital," Goodburn’s direct advocacy is a real opportunity to tear down long-standing barriers to research.
Why it matters
This isn't just about one athlete; it's about systemic change. Brain cancer research has been historically underfunded compared to other types, and Goodburn’s push for a national lead could change how the country treats the disease, potentially giving patients access to life-saving global trials that currently feel out of reach.






